To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Select Committee
The Association of the British Pharmaceutical Industry
 MUL0007 - International relations within the multilateral system

Written Evidence Apr. 16 2024

Inquiry: International relations within the multilateral system
Inquiry Status: Closed
Committee: Foreign Affairs Committee (Department: Foreign, Commonwealth & Development Office)

Found: manufacturing and access to COVID-19 therapeutics. 2.5.

Select Committee
Imperial College London, and University of Bristol

Oral Evidence Apr. 16 2024

Inquiry: Engineering biology
Inquiry Status: Closed
Committee: Science and Technology Committee (Lords)

Found: Imperial College London, and University of Bristol Oral Evidence

Select Committee
High Value Manufacturing Catapult, Airbus UK, and ABPI (The Association of the British Pharmaceutical Industry)

Oral Evidence Apr. 16 2024

Inquiry: Industrial policy
Inquiry Status: Closed
Committee: Business and Trade Committee (Department: Department for Business, Energy and Industrial Strategy)

Found: High Value Manufacturing Catapult, Airbus UK, and ABPI (The Association of the British Pharmaceutical

Departmental Publication (Transparency)
Home Office

Apr. 12 2024

Source Page: Non-technical summaries granted in 2024
Document: Non-technical summaries: projects granted in 2024, January to March (PDF)

Found: Further, our institute regularly engages the public with its research and innovation through public

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Apr. 09 2024

Source Page: MHRA FOI performance data
Document: (Excel)

Found: • Identification and manufacturing information of the version of the 10mg and 20mg tablets used

Departmental Publication (Policy paper)
Foreign, Commonwealth & Development Office

Apr. 02 2024

Source Page: UK-Thailand Strategic Partnership Roadmap
Document: UK-Thailand Strategic Partnership Roadmap (webpage)

Found: ; digital, science, innovation and technology; health; and people-to-people links, education and soft

Departmental Publication (Transparency)
HM Treasury

Mar. 26 2024

Source Page: Whole of Government Accounts, 2021-22
Document: Whole of Government Accounts 2021-22 (web) (PDF)

Found: government and other general Covid -19 responses: Expenditure £bn Protect and Vaccine 0.03

Written Question
Advanced Therapy Medicinal Products: Scotland
Friday 22nd March 2024

Asked by: Ian Murray (Labour - Edinburgh South)

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to help support research into cell and gene therapy in Scotland.

Answered by Andrew Griffith - Minister of State (Department for Science, Innovation and Technology)

The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult (CGTC).

DSIT also invested £10 million - alongside £10 million from Scottish Enterprise – to support a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Glasgow.

The Vaccine Taskforce provided funding for a state-of-the art CGTC facility in Braintree to accelerate the development and manufacturing of advanced therapies at clinical and commercial scale.

My department also supported CGTC to establish apprenticeships and training programmes to upskill people across the UK.

Select Committee
University of Oxford, and British Private Equity and Venture Capital Association (BVCA)

Oral Evidence Mar. 19 2024

Committee: Science and Technology Committee (Lords)

Found: University of Oxford, and British Private Equity and Venture Capital Association (BVCA) Oral Evidence

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 27 November 2023
Document: FOI 23/858 - attachment (PDF)

Found: • Identification and manufacturing information of the version of the 10mg and 20mg tablets